Please try another search
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Name | Age | Since | Title |
---|---|---|---|
Robert A. Anderson | 82 | 2014 | Independent Director |
Gary Rubin | 66 | 2017 | Independent Director |
Peter S. Knight | 71 | 2018 | Independent Director |
Stuart Diamond | 61 | 2022 | Independent Director |
Maria Zannes | 67 | 2014 | Founder, President, CEO & Director |
Steven Girgenti | 77 | 2014 | Founder & Executive Chairman of the Board |
Catherine Sears | - | - | Member of Science & Medical Advisory Board |
Neil Alexis | - | - | Member of Science & Medical Advisory Board |
Gerard A. Silvestri | - | - | Member of Science & Medical Advisory Board |
Sheila Habib | - | 2022 | Member of Scientific & Medical Advisory Board |
Roby P. Joyce | 75 | 2023 | Director |
David G. Hill | - | 2022 | Member of Science & Medical Advisory Board |
Sandeep Bansal | - | 2024 | Member of Science & Medical Advisory Board |
Jamie Platt | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review